Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in a recent study.

A widely used pill for treating an underactive thyroid may be associated with bone loss, according to a study being presented next week at the annual meeting of the Radiological Society of North America in Chicago.

Hypothyroidism (an underactive thyroid) can affect anyone, presenting a slew of unpleasant symptoms like weight gain, fatigue, depression, and hair loss, among other symptoms. When left untreated, it can cause serious and life-threatening conditions.

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasize the need to monitor its use in individuals at risk of negative effects. Levothyroxine, a popular medication used in the treatment of hypothyroidism,

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a synthetic version of a hormone called thyroxine and, according to a recent report from the Radiological Society of North America (RSNA),

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in older adults. Researchers found that even with normal thyroid hormone levels, levothyroxine users experienced greater bone density reduction over a six-year period.